Prosper Faustine Njau, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tanzania | 43 | 2024 | 1407 | 1.570 |
Why?
|
Motivation | 12 | 2024 | 2025 | 1.270 |
Why?
|
HIV Infections | 39 | 2024 | 17591 | 1.250 |
Why?
|
Anti-HIV Agents | 14 | 2024 | 4576 | 0.900 |
Why?
|
Viral Load | 7 | 2024 | 3398 | 0.730 |
Why?
|
Food Supply | 6 | 2019 | 544 | 0.560 |
Why?
|
Resilience, Psychological | 1 | 2023 | 807 | 0.480 |
Why?
|
Anti-Retroviral Agents | 7 | 2022 | 1795 | 0.430 |
Why?
|
Medication Adherence | 6 | 2021 | 2192 | 0.350 |
Why?
|
Pharmaceutical Preparations | 3 | 2021 | 1088 | 0.310 |
Why?
|
Lost to Follow-Up | 2 | 2022 | 123 | 0.200 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2020 | 1360 | 0.200 |
Why?
|
Oxazines | 1 | 2024 | 358 | 0.200 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2203 | 0.200 |
Why?
|
HIV Integrase | 1 | 2023 | 122 | 0.190 |
Why?
|
Reproductive Health Services | 1 | 2023 | 90 | 0.190 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 296 | 0.190 |
Why?
|
Token Economy | 1 | 2020 | 17 | 0.180 |
Why?
|
Selection Bias | 1 | 2022 | 360 | 0.180 |
Why?
|
Young Adult | 18 | 2024 | 60131 | 0.170 |
Why?
|
Lifting | 1 | 2020 | 56 | 0.170 |
Why?
|
Pelvic Organ Prolapse | 1 | 2021 | 116 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
Sexual Behavior | 5 | 2023 | 2200 | 0.160 |
Why?
|
Contraceptive Agents, Female | 1 | 2020 | 123 | 0.160 |
Why?
|
Adolescent | 19 | 2024 | 89244 | 0.150 |
Why?
|
Transportation | 1 | 2020 | 217 | 0.150 |
Why?
|
Self Efficacy | 1 | 2023 | 643 | 0.150 |
Why?
|
Contraception Behavior | 1 | 2020 | 187 | 0.150 |
Why?
|
Contraception | 4 | 2023 | 362 | 0.150 |
Why?
|
Neck Pain | 1 | 2020 | 191 | 0.150 |
Why?
|
Patient Compliance | 3 | 2018 | 2701 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 260 | 0.140 |
Why?
|
Weight-Bearing | 1 | 2020 | 534 | 0.140 |
Why?
|
Condoms | 2 | 2020 | 338 | 0.140 |
Why?
|
Adult | 29 | 2024 | 223851 | 0.140 |
Why?
|
Health Plan Implementation | 1 | 2019 | 338 | 0.140 |
Why?
|
Anxiety | 4 | 2024 | 4672 | 0.140 |
Why?
|
Arthralgia | 1 | 2020 | 459 | 0.130 |
Why?
|
Depression | 3 | 2024 | 8231 | 0.120 |
Why?
|
Emotions | 3 | 2021 | 2768 | 0.120 |
Why?
|
Child Health Services | 1 | 2020 | 645 | 0.120 |
Why?
|
Program Evaluation | 2 | 2021 | 2508 | 0.120 |
Why?
|
Humans | 47 | 2024 | 768970 | 0.120 |
Why?
|
Piperazines | 1 | 2024 | 2553 | 0.110 |
Why?
|
Psychometrics | 1 | 2023 | 3066 | 0.110 |
Why?
|
Agriculture | 1 | 2014 | 187 | 0.100 |
Why?
|
Female | 30 | 2024 | 397515 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2023 | 2666 | 0.100 |
Why?
|
Postpartum Period | 1 | 2019 | 1198 | 0.100 |
Why?
|
Data Collection | 2 | 2023 | 3324 | 0.100 |
Why?
|
Low Back Pain | 1 | 2020 | 990 | 0.090 |
Why?
|
Health Personnel | 1 | 2024 | 3383 | 0.090 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 831 | 0.090 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 26395 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2019 | 2190 | 0.080 |
Why?
|
HIV-1 | 2 | 2024 | 6962 | 0.080 |
Why?
|
Child | 12 | 2024 | 80960 | 0.080 |
Why?
|
Caregivers | 1 | 2021 | 2308 | 0.080 |
Why?
|
Male | 18 | 2024 | 365203 | 0.070 |
Why?
|
Drug Resistance, Viral | 2 | 2023 | 869 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4879 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2649 | 0.070 |
Why?
|
Family Characteristics | 3 | 2017 | 1004 | 0.070 |
Why?
|
Middle Aged | 11 | 2024 | 223737 | 0.070 |
Why?
|
Qualitative Research | 3 | 2023 | 3143 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20245 | 0.060 |
Why?
|
Pregnancy | 6 | 2024 | 30265 | 0.060 |
Why?
|
Continuity of Patient Care | 2 | 2024 | 1076 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3235 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 65480 | 0.050 |
Why?
|
Men | 1 | 2023 | 64 | 0.050 |
Why?
|
HIV Integrase Inhibitors | 1 | 2024 | 165 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5522 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10400 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2021 | 2744 | 0.050 |
Why?
|
Africa | 1 | 2023 | 726 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2024 | 640 | 0.050 |
Why?
|
Integrases | 1 | 2023 | 520 | 0.040 |
Why?
|
Crops, Agricultural | 1 | 2020 | 37 | 0.040 |
Why?
|
Nepal | 1 | 2021 | 301 | 0.040 |
Why?
|
Coal | 1 | 2020 | 122 | 0.040 |
Why?
|
Wood | 1 | 2020 | 95 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2022 | 753 | 0.040 |
Why?
|
Family Planning Services | 1 | 2022 | 279 | 0.040 |
Why?
|
Prevalence | 3 | 2023 | 15879 | 0.040 |
Why?
|
Cognition | 3 | 2021 | 7081 | 0.040 |
Why?
|
Mental Health | 2 | 2024 | 3275 | 0.040 |
Why?
|
Commerce | 1 | 2024 | 613 | 0.040 |
Why?
|
Sexual Partners | 1 | 2023 | 807 | 0.040 |
Why?
|
Technology | 1 | 2021 | 296 | 0.040 |
Why?
|
Genotype | 2 | 2023 | 13048 | 0.040 |
Why?
|
Knee | 1 | 2020 | 278 | 0.040 |
Why?
|
Ankle | 1 | 2020 | 353 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8748 | 0.030 |
Why?
|
Foot | 1 | 2020 | 577 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1599 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1669 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 770 | 0.030 |
Why?
|
Malawi | 1 | 2015 | 312 | 0.030 |
Why?
|
Women's Health | 1 | 2024 | 2081 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1462 | 0.030 |
Why?
|
Pregnant Women | 1 | 2019 | 576 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2193 | 0.030 |
Why?
|
Water | 1 | 2020 | 1421 | 0.030 |
Why?
|
World Health Organization | 1 | 2019 | 1328 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2015 | 740 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1407 | 0.020 |
Why?
|
Vaccination | 1 | 2024 | 3438 | 0.020 |
Why?
|
Headache | 1 | 2020 | 1264 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2020 | 1903 | 0.020 |
Why?
|
Prenatal Care | 1 | 2019 | 1162 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26428 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39394 | 0.020 |
Why?
|
Mothers | 1 | 2020 | 2209 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 74976 | 0.020 |
Why?
|
Pyrimidines | 1 | 2021 | 3048 | 0.020 |
Why?
|
Risk-Taking | 1 | 2014 | 1023 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 30266 | 0.020 |
Why?
|
Schools | 1 | 2017 | 1498 | 0.020 |
Why?
|
Mass Screening | 1 | 2024 | 5457 | 0.020 |
Why?
|
Counseling | 1 | 2015 | 1554 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12562 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12095 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2720 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 4056 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2014 | 2121 | 0.010 |
Why?
|
Self Report | 1 | 2015 | 3773 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14201 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8749 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81903 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42683 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7861 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13055 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54962 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41808 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59739 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36556 | 0.010 |
Why?
|
Aged | 1 | 2019 | 171786 | 0.000 |
Why?
|